News
Learn from NIH’s Michael Salgaller on how to partner with NIH at the Seoul Bio Forum on June 22, 2026. This forum is intended to bring together South Korean biotech and pharma companies with U.S. investors, research institutions, and industry leaders. He will be discussing NIH as a premier
Seven scientists in the United States and Britain who have come up with a revolutionary gene therapy cure for a rare genetic form of childhood blindness won the 2018 António Champalimaud Vision Award, a 1 million euro prize from Portugal’s Champalimaud Foundation. Among them is Michael Redmond
Scientists from the National Institute of Aging (NIA) at National Institutes of Health (NIH) in collaboration with Tawain's National Health Research Institutes and Case Western Reserve University School of Medicine worked with Peptron Inc. a Korean-based public pharmaceutical company to develop a